Related references
Note: Only part of the references are listed.Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
The CK1 family: contribution to cellular stress response and its role in carcinogenesis
Uwe Knippschild et al.
FRONTIERS IN ONCOLOGY (2014)
Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties
Mathieu Bibian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration
Marketa Kaucka et al.
CANCER RESEARCH (2013)
β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression
Babette Schade et al.
CANCER RESEARCH (2013)
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Xiaomei Zhang et al.
CANCER RESEARCH (2013)
WNT10B/-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer
Peter Wend et al.
EMBO MOLECULAR MEDICINE (2013)
Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis
Mejdi Moumen et al.
MOLECULAR CANCER (2013)
Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells
Noah Rodriguez et al.
EMBO MOLECULAR MEDICINE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Impaired CK1 Delta Activity Attenuates SV40-Induced Cellular Transformation In Vitro and Mouse Mammary Carcinogenesis In Vivo
Heidrun Hirner et al.
PLOS ONE (2012)
Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype
Wen-Huan Xu et al.
PLOS ONE (2012)
Wnt Signaling in Cancer
Paul Polakis
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Casein kinase 1: Complexity in the family
Jit Kong Cheong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Targeted therapies for breast cancer
Michaele J. Higgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
Felipe C. Geyer et al.
MODERN PATHOLOGY (2011)
Notch Signaling Pathway as a Therapeutic Target in Breast Cancer
Hamed Al-Hussaini et al.
MOLECULAR CANCER THERAPEUTICS (2011)
IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ε and Wnt/β-catenin independent inhibition of mitotic spindle formation
J. K. Cheong et al.
ONCOGENE (2011)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
So Young Kim et al.
PLOS ONE (2010)
Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway
Christophe Fuerer et al.
PLOS ONE (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Breast cancer-specific mutations in CK1 epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration
Silvie Foldynova-Trantirkova et al.
BREAST CANCER RESEARCH (2010)
Single-vector inducible lentiviral RNAi system for oncology target validation
Dmitri Wiederschain et al.
CELL CYCLE (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo
C. Brockschmidt et al.
GUT (2008)
Disease-associated casein kinase I δ mutation may promote adenomatous polyps formation via a Wnt/β-catenin independent mechanism
I-Chun Tsai et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Wnt-3a utilizes a novel low dose and rapidly pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate β-catenin
Vitezslav Bryja et al.
CELLULAR SIGNALLING (2007)
A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells
Jong In Yook et al.
NATURE CELL BIOLOGY (2006)
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
Greg Finak et al.
BREAST CANCER RESEARCH (2006)
Wnt-dependent regulation of the E-cadherin repressor snail
JI Yook et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Wnt proteins in mammary development and cancer
KR Brennan et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
Breast cancer with synchronous metastases: Trends in survival during a 14-year period
F Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
A Bafico et al.
CANCER CELL (2004)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Wnt signaling in breast cancer: have we come full circle?
AMC Brown
BREAST CANCER RESEARCH (2001)
β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
